CME CirclePrint this Activity for Offline ReferenceInstructions on Taking Medscape CME

Managing Infections in Patients With Hematologic Malignancies CME
Content Development Co-Chairs: Kenneth V. Rolston, MD, John R. Wingard, MD
Disclosures

Release Date: November 25, 2003Valid for credit through November 25, 2004

This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.


This CME/CPE activity "Managing Infections in Patients With Hematologic Malignancies" was originally developed as the curriculum for a CME/CPE Grand Rounds series. If you have already received CME/CPE credit for participating in a Grand Rounds offering of this activity, you cannot receive credit for participating in this online activity.

Contents of This CME Activity
This program is offered in two formats. Please choose one of the versions:

    Flash Version
    (A multimedia presentation with synchronized audio, slides and transcript.)
    Note: Macromedia's Flash Player 5 plug-in is required to view the Flash version.
    Download the Macromedia Flash Player 5 plug-In:

    Get Flash 5

    --OR--

    Slides with transcript and RealAudio:

  1. Overview
    Overview
    Febrile Neutropenia
    Initial Evaluation
    Initial Management

  2. Bacterial Infections
    Bacterial Infections
    Enterococcus Infections
    Streptococcal Infections
    Nosocomial Infections
    Intravascular Devices

  3. Community Respiratory Viruses

  4. Fungal Infections
    Fungal Infections
    Candida Trials and Management
    Caspofungin
    Aspergillus
    Galactomannan Assay
    Treatment Options and Primary Therapy
    Empirical Use of Antifungal Agents
    Empirical Therapy in Febrile Neutropenic Patients
    Less-Common Infections

  5. Special Considerations in the Management of Hematologic Malignancies: Subpopulations
    Special Considerations in the Management of Hematologic Malignancies
    Other Hematologic Malignancies
    Emerging Infections, Vaccination Strategies, and Infection Control

  6. References

These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities. Direct questions or comments to: CME@webmd.net.

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape, The Academy for Healthcare Education, the companies providing educational grants or the authors and writers. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information and consult a qualified healthcare professional before treating patients or utilizing any therapeutic product discussed in this educational activity.

 
Copyright © 2003 Academy for Healthcare Education.



Pfizer

  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME Information
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.